Yonghui Li

4PUBLICATIONS
4CO-AUTHORS
Rehabilitation engineeringHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 14, 2026
EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia.

|Jul 26, 2019
Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen.

Qingyu Xu, Yan Li, Yu Jing

|Jan 15, 2019
The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter.

Guofeng Chen, Anqi Liu, Yihan Xu

|May 26, 2017
A novel epigenetic AML1-ETO/THAP10/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis.

Yonghui Li, Qiaoyang Ning, Jinlong Shi

Pageof 1

Frequent Collaborators

2 joint publications

Li Yu

1 joint publications

Qingyu Xu

1 joint publications

Min Zhang

1 joint publications

Bin Zhang